CU20060177A7 - STABILIZED SUPERSATURED SOLID SOLUTIONS OF STEROID DRUGS - Google Patents

STABILIZED SUPERSATURED SOLID SOLUTIONS OF STEROID DRUGS

Info

Publication number
CU20060177A7
CU20060177A7 CU20060177A CU20060177A CU20060177A7 CU 20060177 A7 CU20060177 A7 CU 20060177A7 CU 20060177 A CU20060177 A CU 20060177A CU 20060177 A CU20060177 A CU 20060177A CU 20060177 A7 CU20060177 A7 CU 20060177A7
Authority
CU
Cuba
Prior art keywords
supersatured
stabilized
solid solutions
steroid drugs
lipophilic
Prior art date
Application number
CU20060177A
Other languages
Spanish (es)
Inventor
Ralph Lipp
Torsten Wagner
Adrian Funke
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Priority to CU20060177A priority Critical patent/CU20060177A7/en
Publication of CU20060177A7 publication Critical patent/CU20060177A7/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica con disolución de drogas lipofílicas mejoradas en un medio acuoso. Se comprobó que composiciones farmacéuticas que comprenden un polvo de compuestos lipofílicos tales como hormonas, y esteroides (por ejemplo, drospirenona y valerato de estradiol) en forma dispersa a nivel molecular junto a un vehículo que posee un área superficial específica de al menos 250 m2/g, tal como dióxido de silicio, por ejemplo, dióxido de silicio comercializado bajo la denominación Aeroperl, posee mejores propiedades de disolución de la droga lipofílica.The present invention relates to a pharmaceutical composition with dissolution of lipophilic drugs improved in an aqueous medium. It was found that pharmaceutical compositions comprising a powder of lipophilic compounds such as hormones, and steroids (for example, drospirenone and estradiol valerate) in a molecularly dispersed form together with a vehicle having a specific surface area of at least 250 m2 / g, such as silicon dioxide, for example, silicon dioxide sold under the name Aeroperl, has better dissolving properties of the lipophilic drug.

CU20060177A 2006-09-11 2006-09-11 STABILIZED SUPERSATURED SOLID SOLUTIONS OF STEROID DRUGS CU20060177A7 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU20060177A CU20060177A7 (en) 2006-09-11 2006-09-11 STABILIZED SUPERSATURED SOLID SOLUTIONS OF STEROID DRUGS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20060177A CU20060177A7 (en) 2006-09-11 2006-09-11 STABILIZED SUPERSATURED SOLID SOLUTIONS OF STEROID DRUGS

Publications (1)

Publication Number Publication Date
CU20060177A7 true CU20060177A7 (en) 2010-04-13

Family

ID=44280804

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20060177A CU20060177A7 (en) 2006-09-11 2006-09-11 STABILIZED SUPERSATURED SOLID SOLUTIONS OF STEROID DRUGS

Country Status (1)

Country Link
CU (1) CU20060177A7 (en)

Similar Documents

Publication Publication Date Title
ECSP066902A (en) STABILIZED SUPERSATURED SOLID SOLUTIONS OF STEROID DRUGS
IL177893A0 (en) Compositions comprising drospirenone molecularly dispersed
MX336930B (en) FORMULATIONS OF GANAXOLONA AND METHODS FOR THE MANUFACTURE AND USE OF THE SAME.
WO2008124617A3 (en) Rapidly dissolving pharmaceutical compositions comprising pullulan
WO2012075081A3 (en) High-strength testosterone undecanoate compositions
BR112014018110A8 (en) AQUEOUS PHARMACEUTICAL COMPOSITIONS FORMULATED FOR PARENTERAL ADMINISTRATION AND USE OF ALLOPREGNANOLOONE AND SULFOBUTYLETHER-B-CYCLODEXTRIN
EA200900572A1 (en) MICELLAR NANOPARTICLES WITH CHEMICAL SUBSTANCES
UY32160A (en) INHALABLE PARTICLES THAT INCLUDE TIOTROPIO
ECSP099577A (en) FORMULATIONS FOR CANCER TREATMENT
HK1220445A1 (en) Compositions with thixotropy and enhanced dissolution reproducibility and stability
PA8853801A1 (en) SILDENAFIL PULSATABLE RELEASE COMPOSITION AND PROCESS TO PREPARE IT
CU20060177A7 (en) STABILIZED SUPERSATURED SOLID SOLUTIONS OF STEROID DRUGS
CY1109564T1 (en) CONSOLIDATED SUPPLIED SUPPLIES OF Fatty Medicines
NZ600539A (en) Parenteral pharmaceutical formulation in suspension, having sustained release, in low and ultralow dosage, in hormonal therapy in the climacteric syndrome
UA87838C2 (en) Stabilised supersaturated solids of lipophilic drugs
MY143870A (en) Molecular dispersions of drospirenone
CL2007003592A1 (en) LIQUID ANTI-CONCEPTIVE FORMULATION FOR MUCOSAL ADMINISTRATION OF THE MOUTH THAT ETONOGESTREL INCLUDES; ANTI-CONCEPTIVE GAME THAT UNDERSTANDS IT; AND USE FOR FEMALE ANTICONCEPTION.
TH75689A (en) Super-saturated lipophilic stabilized solids